In the last trading session, 1.4 million shares of the Structure Therapeutics Inc ADR (NASDAQ:GPCR) were traded, and its beta was -2.77. Most recently the company’s share price was $24.29, and it changed around -$3.11 or -11.35% from the last close, which brings the market valuation of the company to $1.39B. GPCR currently trades at a discount to its 52-week high of $62.74, offering almost -158.3% off that amount. The share price’s 52-week low was $23.50, which indicates that the current value has risen by an impressive 3.25% since then. We note from Structure Therapeutics Inc ADR’s average daily trading volume that its 10-day average is 0.82 million shares, with the 3-month average coming to 878.74K.
Structure Therapeutics Inc ADR stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 13 analysts rate the stock as a Sell; another 6 rate it as Overweight. Among the rest, 0 recommended GPCR as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Structure Therapeutics Inc ADR is expected to report earnings per share of -0.17 for the current quarter.
Structure Therapeutics Inc ADR (NASDAQ:GPCR) trade information
Instantly GPCR has showed a red trend with a performance of -11.35% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 31.33 on recent trading dayincreased the stock’s daily price by 22.47%. The company’s shares are currently down -10.44% year-to-date, but still down -14.32% over the last five days. On the other hand, Structure Therapeutics Inc ADR (NASDAQ:GPCR) is -10.17% down in the 30-day period. We can see from the shorts that 10.44 million shares have been sold at a short interest cover period of 15.69 day(s).
The consensus price target as assigned by Wall Street analysts is $105.5, which translates to bulls needing to increase their stock price by 76.98% from its current value. Analyst projections state that GPCR is forecast to be at a low of $93 and a high of $118.
Forecasts for the next quarter put sales growth at 0.00%.
Structure Therapeutics Inc ADR earnings are expected to increase by 1.18% in 2025, but the outlook is negative -23.68% per year for the next five years.
GPCR Dividends
Structure Therapeutics Inc ADR’s next quarterly earnings report is expected to be released in March.
Structure Therapeutics Inc ADR (NASDAQ:GPCR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.84% of Structure Therapeutics Inc ADR shares, and 107.26% of them are in the hands of institutional investors. The stock currently has a share float of 112.72%.
Smallcap World Fund and Vanguard Specialized-Health Care Fund were the top two Mutual Funds as of Sep 30, 2024 . The former held 4.32 shares worth $104.99 million, making up 7.55% of all outstanding shares. On the other hand, Vanguard Specialized-Health Care Fund held roughly 4.18 shares worth around $101.42 million, which represents about 7.29% of the total shares outstanding.
